Skip to Content

Vanguard Value Index Inv VIVAX

Medalist Rating as of | See Vanguard Investment Hub
  • NAV / 1-Day Return 64.41  /  −0.76 %
  • Total Assets 168.5 Bil
  • Adj. Expense Ratio
    0.170%
  • Expense Ratio 0.170%
  • Distribution Fee Level Low
  • Share Class Type No Load
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment 3,000
  • Status Limited
  • TTM Yield 2.34%
  • Turnover 10%

USD | NAV as of Jul 19, 2024 | 1-Day Return as of Jul 19, 2024, 10:17 PM GMT+0

Morningstar’s Analysis VIVAX

Will VIVAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Cheap and well-diversified value exposure.

Associate Analyst Mo'ath Almahasneh

Mo'ath Almahasneh

Associate Analyst

Summary

We have qualitatively reviewed this strategy and reaffirmed its Above Average Process and People ratings. Vanguard Value constructs a well-diversified, market-cap-weighted basket of U.S. value stocks at a rock-bottom fee, a recipe for success over the long run. The following text is from April 10, 2023.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings VIVAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 22.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Broadcom Inc

3.61 6.1 Bil
Technology

Berkshire Hathaway Inc Class B

2.95 5.0 Bil
Financial Services

JPMorgan Chase & Co

2.81 4.8 Bil
Financial Services

Exxon Mobil Corp

2.50 4.2 Bil
Energy

UnitedHealth Group Inc

2.27 3.8 Bil
Healthcare

Procter & Gamble Co

1.89 3.2 Bil
Consumer Defensive

Johnson & Johnson

1.70 2.9 Bil
Healthcare

The Home Depot Inc

1.65 2.8 Bil
Consumer Cyclical

Merck & Co Inc

1.52 2.6 Bil
Healthcare

AbbVie Inc

1.47 2.5 Bil
Healthcare